A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study

European Urology

Volumn 69, Issue 1, 2016, Pages 94-102

  Thomas, James A ^a   Tubaro, Andrea ^b   Barber, Neil ^c   D'Ancona, Frank ^d   Muir, Gordon ^e   Witzsch, Ulrich ^f   Grimm, Marc Oliver ^g   Benejam, Joan ^h   Stolzenburg, Jens Uwe ⁱ   Riddick, Antony ^j   Pahernik, Sascha ^k   Roelink, Herman ^l   Ameye, Filip ^m   Saussine, Christian ⁿ   Bruyère, Franck ^o,ac   Loidl, Wolfgang ^p   Larner, Tim ^q   Gogoi, Nirjan Kumar ^r   Hindley, Richard ^s   Muschter, Rolf ^m   Thorpe, Andrew ^t   Shrotri, Nitin ^u   Graham, Stuart ^v   Hamann, Moritz ^w   Miller, Kurt ^x   Schostak, Martin ^y   Capitán, Carlos ^z   Knispel, Helmut ^aa   Bachmann, Alexander ^ab   more..

^a PRINCESS OF WALES HOSPITAL   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c FRIMLEY PARK HOSPITAL   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f KRANKENHAUS NORDWEST   (Germany)

^g JENA UNIVERSITY HOSPITAL   (Germany)

^h HOSPITAL DE MANACOR   (Spain)

ⁱ UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^j NHS LOTHIAN   (United Kingdom)

^k UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^l Ziekenhuis Groep Twente   (Netherlands)

^m AZ Maria Middelares Gent ^*  (Germany)

ⁿ UNIVERSITÉ DE STRASBOURG   (France)

^o CHU BRETONNEAU   (France)

^p Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

^q UNIVERSITY OF SUSSEX   (United Kingdom)

^r NATIONAL HEALTH SERVICE   (United Kingdom)

^s BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^t FREEMAN HOSPITAL   (United Kingdom)

^u KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^v WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^w UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^x CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^y UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^z HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^aa MARTIN LUTHER KRANKENHAUS   (Germany)

^ab UNIVERSITY HOSPITAL BASEL   (Switzerland)

^ac UNIVERSITÉ DE TOURS   (France)

more..

Author keywords

Benign prostate obstruction; Benign prostatic hyperplasia; GL XPS; International Prostate Symptom Scores; Lower urinary tract symptoms; Photoselective vaporization of the prostate Quality of Life; Transurethral resection of prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVERSE OUTCOME; ARTICLE; BENIGN PROSTATIC OBSTRUCTION; CONTROLLED STUDY; FOLLOW UP; HUMAN; ICIQ (INCONTINENCE); INTERMETHOD COMPARISON; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OPERATIVE BLOOD LOSS; OVERACTIVE BLADDER QUESTIONNAIRE SHORT FORM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE VOLUME; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION; UROLOGICAL LASER SYSTEM; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; ORGAN SIZE; PATHOLOGY; PATIENT SATISFACTION; PROCEDURES; PROSTATE; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SOLID STATE LASER; THERAPEUTIC USE; URINARY INCONTINENCE;

FOLLOW-UP STUDIES; HUMANS; LASERS, SOLID-STATE; MALE; ORGAN SIZE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 84955688252     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.07.054     Document Type: Article

References (11)

1. C.G. Roehrborn Benighn prostatic hyperplasia: An overview Rev Urol 7 Suppl 9 2005 S3 S14
2. A. Bachmann, A. Tubaro, N. Barber, and et al. 180-W XPS GreenLight laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicenter Randomized Trial-the GOLIATH study Eur Urol 65 2014 931 942
3. A. Bachmann, A. Tubaro, N. Barber, and et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH Study J Urol 19 2015 570 578
4. G. Muir, F. Gomez Sancha, A. Bachmann, and et al. Techniques and training with GreenLight HPS 120-W laser therapy of the prostate: position paper Eur Urol Supp 7 2008 370 377
5. D. Dindo, N. Demartines, and P.-A. Clavien Classification of surgical complications Ann Surg 240 2004 205 213
6. A. Bachmann, H.H. Woo, and S. Wyler Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: a critical review of evidence Curr Opin Urol 22 2012 22 33
7. D.M. Bouchier-Hayes, S. Van Appledorn, P. Bugeja, H. Crowe, B. Challacombe, and A.J. Costello A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up BJU Int 105 2010 964 969
8. P.J. Gilling, L.C. Wilson, C.J. King, A.M. Westenberg, C.M. Frampton, and M.R. Fraundorfer Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years BJU Int 109 2012 408 411
9. M.Y. Hammadeh, S. Madaan, J. Hines, and T. Philp 5-year outcome of a prospective randomized trial to compare transurethral electrovaporization of the prostate and standard transurethral resection Urology 61 2003 1166 1171
10. K.S. Coyne, C.C. Sexton, C. Thompson, T. Bavendam, and L. Brubaker Development and psychometricevaluation of the urgency questionnaire for evaluating severity and health-relatedquality of life impact of urinary urgency in overactive bladder Int Urogynecol J 26 2015 373 382
11. D. Revicki, R.D. Hays, D. Cella, and J. Sloan Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes J Clin Epidemiol 61 2008 102 109